Antibodies News and Research

RSS

IGeneX launches three new tests to aid diagnosis of Borreliosis

IGeneX Inc., a CLIA and New York-approved Reference Laboratory, specializing in testing for tick-borne diseases, is pleased to announce the launch of three new tests that are more inclusive and specific for aiding in diagnosis of Borreliosis (Lyme Disease and Tick-Borne Relapsing Fever, Borreliosis).

16 Oct 2017

Report sheds light on global market for infectious disease immunoassays

Kalorama Information says that infectious disease immunoassays beat the IVD market and the overall IVD market in terms of revenue growth. Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance.

16 Oct 2017

Vaccinated pediatric cancer patients just as likely as unvaccinated peers to develop flu

Young leukemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals. These findings from the St. Jude Children's Research Hospital study appear October 16, 2017, in the Journal of Pediatrics.

16 Oct 2017

New x-ray analysis methodology reveals structure of disordered protein

Scientists at The University of Notre Dame have shown that disordered proteins have a structure very close to what would be expected for a truly random structure using a novel X-ray scattering (SAXS) analysis methodology.

13 Oct 2017

Researchers uncover enzyme behind immune cell response

Monash University researchers have revealed the role played by an enzyme that is pivotal to the process of clearing infection in the body.

12 Oct 2017

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body.

12 Oct 2017

Ebola vaccine that provides a year’s worth of protection developed

Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.

12 Oct 2017

New serotypes of Zika virus could appear in near future, researcher cautions

Zika virus is mutating so fast in Brazilian patients that different serotypes of the pathogen could appear in the near future, as is already the case with dengue virus. This would hinder the production of a vaccine and impair the effectiveness of the diagnostic tests already developed.

10 Oct 2017

New microcapsules represent promising vectors for application of genome-editing tools

Researchers from Tomsk Polytechnic University jointly with their colleagues from St. Petersburg, Hamburg and London have conducted a study in the course of which it was found out that polymer and hybrid silica-coated microcapsules are more efficient in genome-editing when applying CRISPR-Cas9 system.

6 Oct 2017

Ebola vaccine found to be safe and effective for adults and children in Africa

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

6 Oct 2017

Most people in Canada do not know they have celiac disease, research suggests

Research on a large sample of Canadians suggests that most people with celiac disease don't know they have it.

6 Oct 2017

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.

5 Oct 2017

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

A collaborative study conducted by the Miller School of Medicine, University of Miami has revealed that a monoclonal antibody “cocktail” inhibited zika virus (ZIKV) infection in primates.

5 Oct 2017

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc.

5 Oct 2017

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging (MRI) in addition to standard ultrasound (US) because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented during IDWeek 2017.

4 Oct 2017

Novel microscopy technique can more accurately diagnose cancer than current methods

A novel microscopy technique to examine tumour tissue in three dimensions can more accurately diagnose cancer than current two-dimensional methods, according to a study conducted at Karolinska Institutet and Karolinska University Hospital in Sweden. The study is published in Nature Biomedical Engineering.

3 Oct 2017

Benefits of Biomarkers in Colorectal Cancer Treatment

Biomarkers fall into different categories: diagnostic biomarkers, are used to identify a disease; prognostic biomarkers, help clinicians to determine, for example, whether you're more likely to die or have problems with a disease; and there are some that can be used to inform treatment, to determine whether one therapy would be more successful than another.

2 Oct 2017

Scientists explore the reason behind impaired sense of smell in Parkinson's disease

The first symptom of Parkinson's disease is often an impaired sense of smell. This neurodegenerative disease primarily causes irreparable damage to nerve cells in a brain area involved in movement control.

30 Sep 2017

New paper-based test can diagnose Zika infection within 20 minutes

MIT researchers have developed a paper-based test that can diagnose Zika infection within 20 minutes. Unlike existing tests, the new diagnostic does not cross-react with Dengue virus, a close relative of the Zika virus that can produce false positives on many Zika tests.

27 Sep 2017

High-speed method generates mini-protein binders with potential to become new class of drugs

Scientists have created a high-speed method to generate thousands of different, small, stable proteins from scratch that can be custom-designed to bind to specific therapeutic targets.

27 Sep 2017

Antibodies News and Research

IGeneX launches three new tests to aid diagnosis of Borreliosis

Report sheds light on global market for infectious disease immunoassays

Vaccinated pediatric cancer patients just as likely as unvaccinated peers to develop flu

New x-ray analysis methodology reveals structure of disordered protein

Researchers uncover enzyme behind immune cell response

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Ebola vaccine that provides a year’s worth of protection developed

New serotypes of Zika virus could appear in near future, researcher cautions

New microcapsules represent promising vectors for application of genome-editing tools

Ebola vaccine found to be safe and effective for adults and children in Africa

Most people in Canada do not know they have celiac disease, research suggests

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Novel microscopy technique can more accurately diagnose cancer than current methods

Benefits of Biomarkers in Colorectal Cancer Treatment

Scientists explore the reason behind impaired sense of smell in Parkinson's disease

New paper-based test can diagnose Zika infection within 20 minutes

High-speed method generates mini-protein binders with potential to become new class of drugs

Immunology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News